According to the latest research report titled ‘GLOBAL Pharmaceutical Continuous Manufacturing Market 2021-2028’, available with Market Study Report, global pharmaceutical continuous manufacturing market is projected to register an annual growth rate of 10.35% during the forecast period 2021-2028.
 

Rise in number of favorable initiatives undertaken by regulatory authorities, and increasing healthcare expenditure are the major growth propellers of global pharmaceutical continuous manufacturing market growth. Further, progress in large molecules and biologics manufacturing is expected to create new growth avenues in the upcoming years.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552448/
 

On the other hand, poor demand for pharmaceutical continuous manufacturing systems in underdeveloped countries and growing consumer expectations regarding better medicines are negatively impacting the industry outlook.
 

Based on product, global pharmaceutical continuous manufacturing market is categorized into integrated continuous system, semi-continuous system, and control & software. In terms of application scope, the industry is split into API manufacturing and final drug product manufacturing. Moving to the end-user spectrum, the industry is fragmented into contract manufacturing organizations, pharmaceutical companies, and others.
 

Speaking of the geographical outlook, top contributors to the overall pharmaceutical continuous manufacturing market growth are Asia Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries), North America (U.S., Canada), Latin America (Latin America, Brazil), Europe (Russia, Germany, France, Italy, Spain, U.K.), and Middle East and Africa (Turkey, United Arab Emirates, Saudi Arabia, South Africa).
 

Asia Pacific pharmaceutical continuous manufacturing industry size is anticipated at a robust pace over the projected timeline, creditable to heavy investments in pharmaceutical and biopharmaceutical industries, along with rising number of contract research organizations in the region. Moreover, growing presence of industry majors in a bid to extend their operations in emerging nations is bound to create several opportunities for growth in the upcoming years.
 

Speaking of the competitive landscape, Munson Machinery Co., Coperion GmbH, Korsch AG, Gebrüder Lödige Maschinenbau GmbH, Syntegon Technology GmbH, Glatt GmbH, Pfizer, Inc., Eli, Lily & Company, Siemens Healthineers AG, L.B. Bohle Maschinen + Verfahren GmbH, GEA Group AG, and Hosokawa Micron Corp. are the major contenders in global pharmaceutical continuous manufacturing industry sphere.